DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Milestone Pharmaceuticals Q4 EPS $(0.75) Misses $(0.51) Estimate

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.51) by 47.06 percent.

Benzinga · 03/06/2020 12:05

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.51) by 47.06 percent.